Protocol Ledger

NCT04812366 · Phase II · RECRUITING

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

Interventional Phase II clinical trial protocol NCT04812366 sponsored by University of British Columbia in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-09-21 Enrollment: 315 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04812366
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)315 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04812366
Protocol FieldVerified Registry Value
NCT IdentifierNCT04812366
Consolidated Lead SponsorUniversity of British Columbia
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment315 participants (ESTIMATED)
Registered Start Date2021-09-21
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI